Menopause Hormone Therapy in 2025: What’s Changed—and Why It Matters скачать в хорошем качестве

Menopause Hormone Therapy in 2025: What’s Changed—and Why It Matters

The FDA Changed Its Warning. Does that mean you should rethink menopause hormone therapy? Menopause can be a rough experience for many women: Maybe you’re noticing hot flashes, mood swings, or sudden changes with how your clothes are fitting and are trying to figure out what the heck is going on. You talk with your doctor and agree to start menopause hormone therapy. But when you pick it up, you read on the prescription label: WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, BREAST CANCER and PROBABLE DEMENTIA. Uh, no thanks, Doc. You walk away, and continue to suffer. But at least you aren’t getting cancer, having a heart attack, or losing your mind, right? Today, I want to talk about menopause hormone therapy (MHT). I want to address the FDA’s decision to remove this warning from estradiol products and why this is a good thing for both women and medical practitioners. I also want to address the many misconceptions as well as best use cases for MHT. For more information, we recommend the book, Estrogen Matters. You can get your copy of the book here: https://estrogenmatters.com/